Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series
Jonathan Leighton, Carmen Lau, Aisha Savdo, Livia Granata
Background
Cluster headache is an excruciating condition for which standard treatments are usually...
The subject of the new case study is a previously healthy 41-year-old woman who experienced severe Long-COVID symptoms after contracting the virus in February 2022. Despite receiving three vaccinations, she developed a wide range of post-COVID symptoms, including severe anxiety, depression...
Here is the email I received from Younger's Lab this morning:
f you’ve ever taken a psychedelic substance, and you have chronic pain, we’d love to hear more about your experience. We are conducting a brief online survey to learn more about the relationship between chronic pain and classic...
A unified model of ketamine’s dissociative and psychedelic properties
Miriam Marguilho, Inês Figueiredo, and Pedro Castro-Rodrigues
Abstract
Ketamine is an N-methyl-d-aspartate antagonist which is increasingly being researched and used as a treatment for depression. In low doses, it can...
I thought this was generally interesting, shedding some light, as it does, on how ketamine and psychedelics affect the brain structurally, and suggesting the possibility of new drugs for depression and anxiety based on these chemicals.
Ketamine was also suggested and tried as a treatment for ME...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.